Research Interests:

Together with Dr. Lance Liotta, he has formed the Center for Applied Proteomics and Molecular Medicine. The Center has formed a unique partnership between George Mason and Inova Health System. George Mason University-Inova Health System Translational Research Centers is a joint initiative to coordinate multiple programs to implement proteomics, nanotechnology, and genomics research in cancer, metabolic syndrome, cardiopulmonary diseases, and neurodegenerative and liver diseases. This initiative comprises the research efforts of three shared centers: the Center for Applied Proteomics and Molecular Medicine; the Center for Biomedical Genomics; and the Center for the Study of Genomics of Liver Diseases. Inova and George Mason have combined efforts to recruit internationally renowned scientists, such as Lance Liotta and Emanuel Petricoin III, to work closely with clinical investigators from Inova.

Dr. Emanuel Petricoin III
Professor

Email: epetrico@gmu.edu

All Publications of Dr. Petricoin III
Showing results 1 to 10 of 23
Next >>
An investigation into the human serum
M Zhou  D Lucas  K Chan H Issaq  E Petricoin III  L Liotta  T Veenstra  T Conrads             
Electrophoresis   2004 25   1289
 
SERUM PROTEOMIC PROFILING CAN DISCRIMINATE PROSTATE CANCER FROM BENIGN PROSTATES IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2.5 AND 15.0 NG/ML
D Ornstein  W Rayford  V Fusaro T Conrads  S Ross  B Hitt  W Wiggins  T Veenstra  L Liotta  E Petricoin III         
J Urol.   2004 172   1302
 
Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation
R Krieg  R Knuechel  E Schiffmann L Liotta  E Petricoin III  P Herrmann                
Proteomics   2004 4   2789
 
Profiling of normal human leg lymph proteins using the 2-D electrophoresis and SELDI-TOF mass spectrophotometry approach
B Interewicz  W Olszewski  L Leak E Petricoin III  L Liotta                 
Lymphology   2004 37   65
 
Clinical proteomics: Applications for prostate cancer biomarker discovery and detection.
E Petricoin III  D Ornstein  L Liotta                    
Urol Oncol   2004 22   322
 
Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics
E Petricoin III  D Fishman  T Conrads T Veenstra  L Liotta                 
Proteomics   2004 4   2357
 
Protein microarray detection strategies: focus on direct detection technologies
V Espina  E Woodhouse  J Wulfkuhle H Asmussen  E Petricoin III  L Liotta                
J Immunol Methods   2004 290   121
 
Clinical proteomics and biomarker discovery
D Johann Jr  M McGuigan  A Patel S Tomov  S Ross  T Veenstra  D Fishman  G Whiteley  E Petricoin III  L Liotta         
Ann N Y Acad Sci.   2004 1022   295
 
Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection.
E Petricoin III  V Rajapaske  E Herman A Arekani  S Ross  D Johann  A Knapton  J Zhang  B Hitt  T Conrads  T Veenstra  L Liotta  F Sistare   
Toxicol Pathol   2004 32 Suppl 1  122
 
Proteomic analysis of lymph
L Leak  L Liota  H Krutzsch M Jones  V Fusaro  S Ross  Y Zhao  E Petricoin III             
Proteomics   2004 4   1519
 

 

Copyright © 2005 Life Science & GMU | Webmaster | College of Arts and Sciences | GMU | Last update: July 3, 2005